These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 24118335)

  • 1. Refractory thrombotic thrombocytopenic purpura in a 16-year-old girl: successful treatment with bortezomib.
    van Balen T; Schreuder MF; de Jong H; van de Kar NC
    Eur J Haematol; 2014 Jan; 92(1):80-2. PubMed ID: 24118335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report.
    Yates S; Matevosyan K; Rutherford C; Shen YM; Sarode R
    Transfusion; 2014 Aug; 54(8):2064-7. PubMed ID: 24655327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura.
    Mazepa MA; Raval JS; Moll S; Ma A; Park YA
    Br J Haematol; 2014 Mar; 164(6):900-2. PubMed ID: 24345005
    [No Abstract]   [Full Text] [Related]  

  • 4. [Successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Koshino M; Kudou D; Okoshi Y; Obara N; Simizu S; Mukai HY; Suzukawa K; Hasegawa Y; Kojima H; Nagasawa T; Chiba S
    Rinsho Ketsueki; 2010 Feb; 51(2):127-31. PubMed ID: 20379104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.
    Shortt J; Oh DH; Opat SS
    N Engl J Med; 2013 Jan; 368(1):90-2. PubMed ID: 23281998
    [No Abstract]   [Full Text] [Related]  

  • 6. Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura.
    Patriquin CJ; Thomas MR; Dutt T; McGuckin S; Blombery PA; Cranfield T; Westwood JP; Scully M
    Br J Haematol; 2016 Jun; 173(5):779-85. PubMed ID: 27009919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Treatment With Bortezomib for Refractory and Complicated Acquired Thrombotic Thrombocytopenic Purpura in an Adolescent Girl.
    Azapağasi E; Uysal Yazici M; Eroğlu N; Albayrak M; Kucur Ö; Fettah A
    J Pediatr Hematol Oncol; 2021 May; 43(4):e587-e591. PubMed ID: 33306607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab.
    Zheng X; Pallera AM; Goodnough LT; Sadler JE; Blinder MA
    Ann Intern Med; 2003 Jan; 138(2):105-8. PubMed ID: 12529092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rituximab provided long-term remission in a patient with severe thrombotic thrombocytopenic purpura refractory to plasma exchange].
    Hong H; Aoyama Y; Yamamura R; Ohta T; Mugitani A; Yamane T; Hino M; Matsumoto M; Fujimura Y
    Rinsho Ketsueki; 2006 Dec; 47(12):1528-32. PubMed ID: 17233471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays.
    McDonald V; Liesner R; Grainger J; Gattens M; Machin SJ; Scully M
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):245-50. PubMed ID: 20083997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.
    Scully M; Cohen H; Cavenagh J; Benjamin S; Starke R; Killick S; Mackie I; Machin SJ
    Br J Haematol; 2007 Feb; 136(3):451-61. PubMed ID: 17233847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab for treatment of refractory/relapsing thrombotic thrombocytopenic purpura (TTP).
    Ahmad A; Aggarwal A; Sharma D; Dave HP; Kinsella V; Rick ME; Schechter GP
    Am J Hematol; 2004 Oct; 77(2):171-6. PubMed ID: 15389904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.
    Sadler JE
    Blood; 2008 Jul; 112(1):11-8. PubMed ID: 18574040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature.
    Yomtovian R; Niklinski W; Silver B; Sarode R; Tsai HM
    Br J Haematol; 2004 Mar; 124(6):787-95. PubMed ID: 15009067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acquired thrombotic thrombocytopenic purpura (TTP) with plasma infusion plus rituximab.
    Hagel S; Jantsch J; Budde U; Kalden JR; Eckardt KU; Veelken R
    Thromb Haemost; 2008 Jul; 100(1):151-3. PubMed ID: 18612551
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura. A case report and concise review of the literature.
    Rüfer A; Brodmann D; Gregor M; Kremer Hovinga JA; Lämmle B; Wuillemin WA
    Swiss Med Wkly; 2007 Sep; 137(37-38):518-24. PubMed ID: 17990141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
    Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M
    Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current insight into thrombotic thrombocytopenic purpura.
    Verbeke L; Delforge M; Dierickx D
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):3-10. PubMed ID: 19851089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of relapsing autoimmune thrombotic thrombocytopenic purpura with rituximab.
    Sankararaman S; Jeroudi M; Ibrahim H
    Pediatr Int; 2014 Dec; 56(6):914-918. PubMed ID: 25521977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib.
    Moore H; Romeril K
    Intern Med J; 2011 Apr; 41(4):348-50. PubMed ID: 21507163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.